Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biochip technologies in cancer research.

O P Kallioniemi1

  • 1Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. okalli@nhgri.nih.gov

Annals of Medicine
|May 1, 2001
PubMed
Summary

Biochip technologies accelerate biological studies and disease research by enabling high-throughput molecular analysis. These advancements are revolutionizing cancer research, diagnostics, and personalized treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility.

Oncogene·2006
Same author

[Susceptibility genes of familial breast cancer in Finland].

Duodecim; laaketieteellinen aikakauskirja·2002
Same author

Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families.

European journal of human genetics : EJHG·2002
Same author

Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling.

Oncogene·2001
Same author

Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

The American journal of pathology·2001
Same author

Association of E-cadherin germ-line alterations with prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Cancer Research

Background:

  • High-throughput biochip technologies have significantly advanced biological studies and disease research.
  • Biochips allow for miniaturized, massively parallel molecular analyses with very high throughput.

Purpose of the Study:

  • To review the applications of various biochip technologies in cancer research.
  • To highlight how biochips aid in understanding disease predisposition, gene expression, protein interactions, and tissue analysis.

Main Methods:

  • Review of single-nucleotide polymorphism (SNP) microarrays for disease predisposition.
  • Analysis of cDNA microarrays for global gene expression patterns.
  • Utilizing proteomic biochips for protein analysis and tissue microarrays for cellular and clinical endpoint assessment.

Main Results:

  • Biochip applications span from genetic predisposition analysis to global gene and protein profiling.
  • Tissue microarrays enable the study of cell types, tissues, and molecular targets in cancer.

Conclusions:

  • Future cancer risk assessment will likely rely on microarray profiles of single-nucleotide polymorphisms (SNPs).
  • Biochip-based diagnostics, analyzing thousands of genes and proteins, will facilitate cancer diagnosis.
  • Integrated biochip diagnostics and informatics will underpin individualized cancer treatment decisions.

Related Experiment Videos